白细胞介素-1阻断逆转全身型幼年特发性关节炎患者中性粒细胞的脓毒症样特征
研究分析了50例接受重组白细胞介素-1受体拮抗剂(rIL-1Ra;阿那白滞素)治疗的全身型幼年特发性关节炎(JIA)患者,发现疾病起病时中性粒细胞计数显著升高并与炎症介质水平相关,rIL-1Ra治疗数日内恢复正常;RNA测序显示活动期患者中性粒细胞炎症过程显著上调,与脓毒症转录组显著重叠,且rIL-1Ra可逆转中性粒细胞的 priming 表型。病程短者中性粒细胞计数高、未成熟中性粒细胞多且对rIL-1Ra完全应答,而症状持续>1个月者中性粒细胞计数正常且应答不满意。
要点
- 全身型JIA起病时中性粒细胞计数显著升高且与炎症介质水平相关,rIL-1Ra治疗数日内恢复正常
- 活动期患者中性粒细胞炎症转录程序显著上调,与脓毒症转录组显著重叠
- rIL-1Ra可逆转中性粒细胞priming表型,病程短者完全应答而病程>1个月者应答不满意
核心结论
- 结果强烈支持中性粒细胞在全身型JIA中发挥重要作用,尤其在疾病早期炎症阶段。
- 中性粒细胞数量和全身型JIA的炎症活动均对IL-1阻断敏感。
研究设计与样本
- 研究分析了50例接受rIL-1Ra(阿那白滞素)治疗的全身型JIA患者,在疾病起病时和缓解期进行评估。
- 对3例活动期全身型JIA患者和3例健康对照的荧光激活细胞分选中性粒细胞进行RNA测序。
- 用流式细胞术评估17例全身型JIA患者和15例健康对照血清样本中中性粒细胞的活化标志物表达、凋亡、活性氧(ROS)产生和分泌囊泡脱颗粒。
- 体外实验检测rIL-1Ra对健康受试者中性粒细胞IL-1β priming效应的拮抗作用。
主要发现
- 疾病起病时中性粒细胞计数显著增高,且与炎症介质水平相关;开始rIL-1Ra治疗后数日内中性粒细胞计数恢复正常。
- RNA测序显示活动期全身型JIA患者中性粒细胞炎症过程显著上调,与脓毒症转录组显著重叠。
- 活动期患者中性粒细胞呈现priming表型,特征为ROS产生增加、CD62L脱落和分泌囊泡脱颗粒,在达到临床缓解的患者中该表型被rIL-1Ra治疗逆转。
- 病程短者中性粒细胞计数高、未成熟中性粒细胞更多且对rIL-1Ra完全应答,而症状持续>1个月者中性粒细胞计数正常且对rIL-1Ra应答不满意。
- 体外实验中rIL-1Ra拮抗了IL-1β对健康受试者中性粒细胞的priming效应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Neutrophils are the most abundant innate immune cells in the blood, but little is known about their role in (acquired) chronic autoinflammatory diseases. This study was undertaken to investigate the role of neutrophils in systemic-onset juvenile idiopathic arthritis (JIA), a prototypical multifactorial autoinflammatory disease that is characterized by arthritis and severe systemic inflammation. METHODS: Fifty patients with systemic-onset JIA who were receiving treatment with recombinant interleukin-1 receptor antagonist (rIL-1Ra; anakinra) were analyzed at disease onset and during remission. RNA sequencing was performed on fluorescence-activated cell-sorted neutrophils from 3 patients with active systemic-onset JIA and 3 healthy controls. Expression of activation markers, apoptosis, production of reactive oxygen species (ROS), and degranulation of secretory vesicles from neutrophils were assessed by flow cytometry in serum samples from 17 patients with systemic-onset JIA and 15 healthy controls. RESULTS: Neutrophil counts were markedly increased at disease onset, and this correlated with the levels of inflammatory mediators. The neutrophil counts normalized within days after the initiation of rIL-1Ra therapy. RNA-sequencing analysis revealed a substantial up-regulation of inflammatory processes in neutrophils from patients with active systemic-onset JIA, significantly overlapping with the transcriptome of sepsis. Correspondingly, neutrophils from patients with active systemic-onset JIA displayed a primed phenotype that was characterized by increased ROS production, CD62L shedding, and secretory vesicle degranulation, which was reversed by rIL-1Ra treatment in patients who had achieved clinical remission. Patients with a short disease duration had high neutrophil counts, more immature neutrophils, and a complete response to rIL-1Ra, whereas patients with symptoms for >1 month had normal neutrophil counts and an unsatisfactory response to rIL-1Ra. In vitro, rIL-1Ra antagonized the priming effect of IL-1β on neutrophils from healthy subjects. CONCLUSION: These results strongly support the notion that neutrophils play an important role in systemic-onset JIA, especially in the early inflammatory phase of the disease. The findings also demonstrate that neutrophil numbers and the inflammatory activity of systemic-onset JIA are both susceptible to IL-1 blockade.
引用
- Ter Haar NM, Tak T, Mokry M, et al. Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2018. PMID: 29426067. doi:10.1002/art.40442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。